Octagon Capital Advisors’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,637,076
Closed -$8.11M 33
2025
Q1
$8.11M Sell
4,637,076
-211,726
-4% -$279K 1.6% 24
2024
Q4
$7.66M Buy
4,848,802
+585,101
+14% +$899K 1.3% 25
2024
Q3
$6.69M Hold
4,263,701
1.07% 25
2024
Q2
$7.61M Buy
+4,263,701
New +$9.9M 1.26% 23

Other funds holding RGLS